Your browser doesn't support javascript.
Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements.
Spetz, Joanne; Hailer, Laurie; Gay, Caryl; Tierney, Matthew; Schmidt, Laura; Phoenix, Bethany; Chapman, Susan.
  • Spetz J; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
  • Hailer L; Healthforce Center at UCSF, University of California, San Francisco.
  • Gay C; Department of Family and Community Medicine, University of California, San Francisco.
  • Tierney M; Department of Social and Behavioral Sciences, University of California, San Francisco.
  • Schmidt L; Department of Community Health Systems, University of California, San Francisco.
  • Phoenix B; Quantgal LLC, Fairfax, California.
  • Chapman S; Department of Family Health Nursing, University of California, San Francisco.
JAMA Netw Open ; 5(5): e225996, 2022 05 02.
Article in English | MEDLINE | ID: covidwho-1843822
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article